EBITDA margin společnosti Interpace Biosciences Inc
Jaká je hodnota metriky EBITDA margin společnosti Interpace Biosciences Inc?
Hodnota metriky EBITDA margin společnosti Interpace Biosciences Inc je -88.65%
Jaká je definice metriky EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Interpace Biosciences Inc
Čemu se věnuje společnost Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Firmy s metrikou ebitda margin podobnou společnosti Interpace Biosciences Inc
- Hodnota metriky EBITDA margin společnosti Zhongtian International je -89.61%
- Hodnota metriky EBITDA margin společnosti Imperium Global je -89.60%
- Hodnota metriky EBITDA margin společnosti Cashwerkz je -89.43%
- Hodnota metriky EBITDA margin společnosti Ur- je -89.04%
- Hodnota metriky EBITDA margin společnosti PointsBet je -88.99%
- Hodnota metriky EBITDA margin společnosti PointsBet je -88.99%
- Hodnota metriky EBITDA margin společnosti Interpace Biosciences Inc je -88.65%
- Hodnota metriky EBITDA margin společnosti LION E-Mobility AG je -88.63%
- Hodnota metriky EBITDA margin společnosti Amatheon Agri N.V je -88.58%
- Hodnota metriky EBITDA margin společnosti Flow Beverage je -88.50%
- Hodnota metriky EBITDA margin společnosti SNDL Inc je -88.46%
- Hodnota metriky EBITDA margin společnosti The Supreme Cannabis Co je -88.42%
- Hodnota metriky EBITDA margin společnosti The Supreme Cannabis je -88.42%